BAUSCH HEALTH COMPANIES INC. |
Real-time Estimate
Other stock markets
|
5-day change | 1st Jan Change | ||
| 7.085 USD | -0.49% |
|
+1.00% | -11.47% |
| 06:59pm | RBC Notes Updates on Bausch Xifaxan Patent Litigation with Norwich | MT |
| 14/05 | Bausch Health Down 6.6% In US After Hours As Updates Related to Norwich XIFAXAN Matters | MT |
"Total Return" performance includes dividend payments over the period, as if they were reinvested at 100%.
End-of-day quotes
End-of-day quotes
Compared values
| Sector | Change | 5d. change | 1st Jan change | 1-year change | 5-years change | Capi. | ST | MT | LT | ||
|---|---|---|---|---|---|---|---|---|---|---|---|
| BAUSCH HEALTH COMPANIES INC. | Other Pharmaceuticals | -0.28% | +1.00% | -11.47% | +17.74% | -71.91% | 261.16Cr |  |  | |
Technical Rankings Surperformance
- Stock Market
- Equities
- BHC Stock
- Charts Bausch Health Companies Inc.
- Comparison Chart